| |
Control-patients
(N=15) |
Obese –normotensive patients
(N=20) |
Obese hypertensive patients
(N=20) |
| Glucose (mg/dl) |
r=0.33
P<0.05 |
r=0.35
P<0.05 |
r=0.35
P<0.05 |
| Insulin(μIU/ml) |
r=0.32
P<0.05 |
r=0.31
P<0.05 |
r=0. 34
P<0.05 |
| HOMA IR-index |
r=0.29
P<0.05 |
r=0.30
P<0.05 |
r=0.33
P<0.05 |
| TG(mg/dl) |
r=0.26
P<0.05 |
r=0.31
P<0.05 |
r=0.34
P<0.05 |
| TC(mg/dl) |
r=0.15
P<0.05 |
r=0.21
P<0.05 |
r=0.27
P<0.05 |
| LDL-C(mg/dl) |
r=0.22
P<0.05 |
r=0.28
P<0.05 |
r=0.33
P<0.05 |
| HDL-C (mg/dl) |
r=0.24
P<0.05 |
r=0.24
P<0.05 |
r=0.26
P<0.05 |
| TNF-α (ng/ml) |
r=0.29
P<0.05 |
r=0.31
P<0.05 |
r=0.38
P<0.05 |
| IL-6(ng/ml) |
r=0.15
P<0.05 |
r=0.17
P<0.05 |
r=0.22
P<0.05 |
| IL-23(ng/ml) |
r=0.30
P<0.05 |
r=0.29
P<0.05 |
r=0.33
P<0.05 |
HOMA IR-index, Homeostasis Model of Assessment - Insulin Resistance; TG,
triglycerides; TC, total cholesterol; LDL-c, low density lipoprotein-cholesterol;
HDL-c, High density lipoprotein-cholesterol; TNF-α, tumor necrosis factor-alpha;
IL-6, interleukin-6; IL-23, interleukin-23. |
